Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas

被引：0
|
作者：
T. Ebata
M. Yunokawa
S. Bun
A. Shimomura
T. Shimoi
M. Kodaira
K. Yonemori
C. Shimizu
Y. Fujiwara
T. Kato
K. Tamura
机构：
[1] Chiba University,Department of Medical Oncology
[2] National Cancer Center Hospital,Department of Breast and Medical Oncology
[3] National Cancer Center Hospital,Department of Pharmacy
[4] National Cancer Center Hospital,Department of Gynecology
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 78卷
关键词：
Ovarian cancer; Carboplatin; Paclitaxel; Dose-dense therapy; Neoadjuvant chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1283 / 1288
页数：5
相关论文
共 50 条
  • [1] Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube, or primary peritoneal carcinomas
    Ebata, T.
    Yunokawa, M.
    Bun, S.
    Shimomura, A.
    Shimoi, T.
    Kodaira, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Kato, T.
    Tamura, K.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (06) : 1283 - 1288
  • [2] Dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian, and primary peritoneal carcinomas
    Takahiro, E.
    Kodaira, M.
    Shimoi, T.
    Shimomura, A.
    Yunokawa, M.
    Yonemori, K.
    Shimizu, C.
    Fujiwara, Y.
    Tamura, K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S547 - S547
  • [3] Efficacy and safety of dose-dense paclitaxel plus carboplatin as neoadjuvant chemotherapy for advanced ovarian, fallopian tube or peritoneal cancer
    Yoshihama, Tomoko
    Nomura, Hiroyuki
    Iwasa, Naomi
    Kataoka, Fumio
    Hashimoto, Shiho
    Nanki, Yoshiko
    Hirano, Takuro
    Makabe, Takeshi
    Sakai, Kensuke
    Yamagami, Wataru
    Hirasawa, Akira
    Aoki, Daisuke
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (11) : 1019 - 1023
  • [4] Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study
    Shibutani, Takashi
    Nagao, Shoji
    Suzuki, Kazuhiro
    Kaneda, Michiko
    Yamamoto, Kasumi
    Jimi, Tomoatsu
    Yano, Hiroko
    Kitai, Miho
    Shiozaki, Takaya
    Matsuoka, Kazuko
    Sudo, Tamotsu
    Yamaguchi, Satoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (03) : 502 - 507
  • [5] Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study
    Takashi Shibutani
    Shoji Nagao
    Kazuhiro Suzuki
    Michiko Kaneda
    Kasumi Yamamoto
    Tomoatsu Jimi
    Hiroko Yano
    Miho Kitai
    Takaya Shiozaki
    Kazuko Matsuoka
    Tamotsu Sudo
    Satoshi Yamaguchi
    International Journal of Clinical Oncology, 2020, 25 : 502 - 507
  • [6] PROSPECTIVE FEASIBILITY STUDY OF NEOADJUVANT DOSE-DENSE PACLITAXEL PLUS CARBOPLATIN WITH BEVACIZUMAB THERAPY FOR ADVANCED OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CANCER PATIENTS
    Nomura, H.
    Iwasa, N.
    Kataoka, F.
    Chiyoda, T.
    Yamagami, W.
    Fujii, T.
    Aoki, D.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A150 - A150
  • [7] Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients
    Iwasa-Inoue, Naomi
    Nomura, Hiroyuki
    Kataoka, Fumio
    Chiyoda, Tatsuyuki
    Yoshihama, Tomoko
    Nanki, Yoshiko
    Sakai, Kensuke
    Kobayashi, Yusuke
    Yamagami, Wataru
    Morisada, Tohru
    Hirasawa, Akira
    Aoki, Daisuke
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2022, 27 (02) : 441 - 447
  • [8] Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients
    Naomi Iwasa-Inoue
    Hiroyuki Nomura
    Fumio Kataoka
    Tatsuyuki Chiyoda
    Tomoko Yoshihama
    Yoshiko Nanki
    Kensuke Sakai
    Yusuke Kobayashi
    Wataru Yamagami
    Tohru Morisada
    Akira Hirasawa
    Daisuke Aoki
    International Journal of Clinical Oncology, 2022, 27 : 441 - 447
  • [9] Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer
    Bun, Seiko
    Yunokawa, Mayu
    Ebata, Takahiro
    Shimomura, Akihiko
    Shimoi, Tatsunori
    Kodaira, Makoto
    Yonemori, Kan
    Shimizu, Chikako
    Fujiwara, Yasuhiro
    Kato, Tomoyasu
    Makino, Yoshinori
    Hayashi, Yoshikazu
    Tamura, Kenji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (04) : 745 - 752
  • [10] Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer
    Seiko Bun
    Mayu Yunokawa
    Takahiro Ebata
    Akihiko Shimomura
    Tatsunori Shimoi
    Makoto Kodaira
    Kan Yonemori
    Chikako Shimizu
    Yasuhiro Fujiwara
    Tomoyasu Kato
    Yoshinori Makino
    Yoshikazu Hayashi
    Kenji Tamura
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 745 - 752
12345